PACS Group, Inc. (PACS)
NYSE: PACS · IEX Real-Time Price · USD
28.30
-0.05 (-0.18%)
At close: May 16, 2024, 4:00 PM
28.92
+0.62 (2.19%)
After-hours: May 16, 2024, 7:49 PM EDT
PACS Group Revenue
Revenue in the quarter ending March 31, 2024 was $934.72M. In the year 2023, PACS Group had annual revenue of $3.11B with 28.47% growth.
Revenue (ttm)
$3.11B
Revenue Growth
+28.47%
P/S Ratio
0.21
Revenue / Employee
$95,936
Employees
32,433
Market Cap
702.32M
Revenue Chart
* The company reports in USD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.11B | 689.50M | 28.47% |
Dec 31, 2022 | 2.42B | 1.26B | 107.62% |
Dec 31, 2021 | 1.17B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPACS News
- 3 days ago - PACS Group Announces Appointment of Evelyn Dilsaver to Serve as Independent Board Director - Business Wire
- 3 days ago - PACS Group, Inc. Reports First Quarter 2024 Results - Business Wire
- 10 days ago - PACS Group to Announce First Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - PACS Group, Inc. Announces Closing of Its Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares from the Selling Stockholders - Business Wire
- 5 weeks ago - Healthcare firm PACS Group's shares rise 9% in NYSE debut - Reuters
- 5 weeks ago - PACS Group, Inc. Announces Pricing of Its Upsized Initial Public Offering - Business Wire
- 6 weeks ago - Healthcare firm PACS Group eyes up to $3.25 bln valuation in US IPO - Reuters
- 2 months ago - Post-acute healthcare provider PACS Group files for an estimated $500 million IPO - Renaissance Capital